Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Piga

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
American Journal of Hypertension|June 20, 1998
Blood pressure and heart rate in young thalassemia major patientsF Veglio, R Melchio, F Rabbia, et al.
Blood|April 15, 1990
Deletion delta-thalassemia: the 7.2 kb deletion of Corfu delta beta-thalassemia in a non-beta-thalassemia chromosomeR Galanello, M A Melis, A Podda, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
The value of necropsy in oncologyL Di Furia, A Piga, S Marmili, et al.
American Journal of Clinical Oncology|August 1, 1996
Assessing quality of life in patients with cancer: a comparison of a visual-analogue and a categorical modelF Giorgi, R Cellerino, A Gramazio, et al.
Archives of Disease in Childhood|February 1, 1982
Haemoglobin levels and blood requirement in thalassaemiaV Gabutti, A Piga, P Nicola, et al.
Lancet (London, England)|December 5, 1981
Therapeutic selectivity of and predication of response to 2'-deoxycoformycin in acute leukaemiaH G Prentice, N H Russell, N Lee, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 7, 2000
Cisplatin, epirubicin and cyclophosphamide (PEC) in the treatment of advanced ovarian cancerC Massacesi, R Bascioni, R Cellerino, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Loss of hMLH1 expression correlates with improved survival in stage III-IV ovarian cancer patientsM Scartozzi, M De Nictolis, E Galizia, et al.
Blood|April 21, 2001
New mutations inactivating transferrin receptor 2 in hemochromatosis type 3A Roetto, A Totaro, A Piperno, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 13, 1998
A double blind randomized study of oral clodronate in the treatment of bone metastases from tumors poorly responsive to chemotherapyA Piga, R Bracci, B Ferretti, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
American Journal of Hypertension|June 20, 1998
Blood pressure and heart rate in young thalassemia major patientsF Veglio, R Melchio, F Rabbia, et al.
Blood|April 15, 1990
Deletion delta-thalassemia: the 7.2 kb deletion of Corfu delta beta-thalassemia in a non-beta-thalassemia chromosomeR Galanello, M A Melis, A Podda, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
The value of necropsy in oncologyL Di Furia, A Piga, S Marmili, et al.
American Journal of Clinical Oncology|August 1, 1996
Assessing quality of life in patients with cancer: a comparison of a visual-analogue and a categorical modelF Giorgi, R Cellerino, A Gramazio, et al.
Archives of Disease in Childhood|February 1, 1982
Haemoglobin levels and blood requirement in thalassaemiaV Gabutti, A Piga, P Nicola, et al.
Lancet (London, England)|December 5, 1981
Therapeutic selectivity of and predication of response to 2'-deoxycoformycin in acute leukaemiaH G Prentice, N H Russell, N Lee, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 7, 2000
Cisplatin, epirubicin and cyclophosphamide (PEC) in the treatment of advanced ovarian cancerC Massacesi, R Bascioni, R Cellerino, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Loss of hMLH1 expression correlates with improved survival in stage III-IV ovarian cancer patientsM Scartozzi, M De Nictolis, E Galizia, et al.
Blood|April 21, 2001
New mutations inactivating transferrin receptor 2 in hemochromatosis type 3A Roetto, A Totaro, A Piperno, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 13, 1998
A double blind randomized study of oral clodronate in the treatment of bone metastases from tumors poorly responsive to chemotherapyA Piga, R Bracci, B Ferretti, et al.
Pageof 13